Hepatocellular Carcinoma with Radiological Progression: Lenvatinib Plus PD-1 Inhibitor Combined with Microwave Ablation and Synchronous Transarterial Chemoembolization

Qin Shi1 Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, People’s Republic of China;2 Shanghai Institution of Medical Imaging, Fudan University, Shanghai, 200032, People’s Republic of China;3 National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, People’s Republic of ChinaView further author information

Peng Huang2 Shanghai Institution of Medical Imaging, Fudan University, Shanghai, 200032, People’s Republic of China;4 Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, People’s Republic of ChinaView further author information

Zihan Zhang1 Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, People’s Republic of China;2 Shanghai Institution of Medical Imaging, Fudan University, Shanghai, 200032, People’s Republic of China;3 National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, People’s Republic of ChinaView further author information

Wen Zhang1 Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, People’s Republic of China;2 Shanghai Institution of Medical Imaging, Fudan University, Shanghai, 200032, People’s Republic of China;3 National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, People’s Republic of ChinaView further author information

Lingxiao Liu1 Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, People’s Republic of China;2 Shanghai Institution of Medical Imaging, Fudan University, Shanghai, 200032, People’s Republic of China;3 National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information

Zhiping Yan1 Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, People’s Republic of China;2 Shanghai Institution of Medical Imaging, Fudan University, Shanghai, 200032, People’s Republic of China;3 National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, People’s Republic of ChinaView further author information

Hepatocellular Carcinoma with Radiological Progression: Lenvatinib Plus PD-1 Inhibitor Combined with Microwave Ablation and Synchronous Transarterial Chemoembolization

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Hepatocellular Carcinoma with Radiological Progression: Lenvatinib Plus PD-1 Inhibitor Combined with Microwave Ablation and Synchronous Transarterial Chemoembolization

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date